FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Cellular topics
Access Point
Neural Stimulation
Neurological
Ceramic Substrate
Communications
Die Assembly
Extracellular
Computing Device
Discomfort
Circuit Board
Modulation
Passive Intermodulation
Distributed
Transceiver
Distributed Antenna System

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Cellular patents



      
           
This page is updated frequently with new Cellular-related patent applications. Subscribe to the Cellular RSS feed to automatically get the update: related Cellular RSS feeds. RSS updates for this page: Cellular RSS RSS


Modified gram positive bacteria and uses thereof

Methods of manufacturing drug-loaded substrates

Method and system for processing cancer cell electrical signals for medical therapy

Date/App# patent app List of recent Cellular-related patents
08/14/14
20140230080
 Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver patent thumbnailnew patent Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver
The present invention provides (1) a method for producing a non-human animal having a humanized liver, comprising transplanting human hepatic stem cells and/or hepatic progenitor cells and/or immature hepatocytes to a liver-damaged non-human animal to induce the differentiation of the cells into hepatocytes, (2) a non-human animal having a humanized liver, produced by the method, (3) a method for examining the pharmacokinetics and/or hepatotoxicity of a test substance, comprising using the animal, (4) a method for producing human hepatocytes, comprising transplanting human hepatic stem cells and/or hepatic progenitor cells and/or immature hepatocytes to a liver-damaged non-human animal to induce the differentiation of the cells into hepatocytes, and (5) a method for examining the pharmacokinetics and/or hepatotoxicity of a test substance, comprising using human hepatocytes produced by the method.. .
08/14/14
20140230026
 Biometric-based access control system comprising a near field communication link patent thumbnailnew patent Biometric-based access control system comprising a near field communication link
The subject invention is directed to a class of biometric-based authentication methods and devices that can be utilized to control access to any electronic device or electronically-controlled device. Certain embodiments include a touch sensitive device including a transparent input device (e.g., a touchscreen) or opaque input device (e.g., a touchpad).
08/14/14
20140228972
 Biodegradable metallic medical implants, method for preparing and use thereof patent thumbnailnew patent Biodegradable metallic medical implants, method for preparing and use thereof
A medical implant includes a metal composite that comprises a cellular nanomatrix comprising a metallic nanomatrix material and a metal matrix disposed in the cellular nanomatrix, the medical implant being configured to disintegrate in response to contact with a fluid. A method for repairing tissue includes disposing an implant in a patient, the implant comprising a metal composite which comprises: a cellular nanomatrix comprising a metallic nanomatrix material; and a metal matrix disposed in the cellular nanomatrix; contacting tissue of the patient with the implant, the tissue being in need of repair; and non-operatively removing the implant to repair the tissue..
08/14/14
20140228970
 Tissue engineering device and construction of vascularized dermis patent thumbnailnew patent Tissue engineering device and construction of vascularized dermis
An inkjet printing method, system, and computer-usable tangible storage device to print cells and biomaterials for three-dimensional cellular scaffolds and engineered skin grafts are disclosed. The process simultaneously deposits living cells, nutrients, growth factors, therapeutic drugs along with biomaterial scaffolds at the right time and location.
08/14/14
20140228933
 Methods for modifying vascular vessel walls patent thumbnailnew patent Methods for modifying vascular vessel walls
This invention relates in one aspect to the treatment of a vascular vessel with a biomaterial. The biomaterial can be a remodelable material that strengthens and/or supports the vessel walls.
08/14/14
20140228910
 Method and system for processing cancer cell electrical signals for medical therapy patent thumbnailnew patent Method and system for processing cancer cell electrical signals for medical therapy
A scientific computer system with processor capable of recording, storing, and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system.
08/14/14
20140228904
 System for seamless and secure networking of implantable medical devices, electronic patch devices and wearable devices patent thumbnailnew patent System for seamless and secure networking of implantable medical devices, electronic patch devices and wearable devices
A system level scheme for networking of implantable devices, electronic patch devices/sensors coupled to the body, and wearable sensors/devices with cellular telephone/mobile devices, peripheral devices and remote servers is described.. .
08/14/14
20140228620
 Sequentially programmed magnetic field therapeutic system (spmf) patent thumbnailnew patent Sequentially programmed magnetic field therapeutic system (spmf)
A comprehensive system for inducing cellular regeneration and/or degeneration processes and methods of treatment based on such processes through generating and applying a sequentially programmed magnetic field (spmf) to the area to be treated. In the case of regeneration and degeneration of cells, the pulsing frequencies are in the range of about 0.1 to about 2000 hz based on the indication of the disease type which was determined by either the patient's mri, ct, ultrasound or other diagnostic information.
08/14/14
20140228516
 Bispecific intracellular delivery vehicles patent thumbnailnew patent Bispecific intracellular delivery vehicles
A composition for delivering an agent to a cell, comprising a bispecific affinity reagent and a ph-responsive, membrane destabilizing polymer. The bispecific affinity reagent may include a first affinity reagent covalently linked to a second affinity reagent, wherein the first affinity reagent binds to a molecule on the surface of a cell, and the second affinity reagent binds to an intracellular target..
08/14/14
20140228460
 Interconnected microcellular material made of industrial lignin and method for preparing same patent thumbnailnew patent Interconnected microcellular material made of industrial lignin and method for preparing same
An interconnected microcellular material, a method for preparing said material using low-value waste from the paper industry, such as industrial lignin, and the use thereof for the production of items such as catalysts, filters or absorbent elements.. .
08/14/14
20140228375
new patent Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity
The present invention involves new and original sigma receptors ligands: (mono-or dialkylaminoalkyl)-γ-butyrolactones, their analogues aminotetrahydroturanes, the (1-adamantyl) benzene alkylamines, the n,n dialkyl α-[(adamantyl-1)benzyloxy-2] alkylamines and the 3-cyclopentyl adamantyl-amines or alkylamines or-alkyl phenylamines, their enantiomers or diastereoisomers, their pharmaceutically acceptable salts and quinacrine me-thylene blue, asteinizole and their relative analogues with pro-apoptotic and/or anti-apoptotic properties over cellular biochemical mechanisms, with prototypical anti-cancer, antimetastatic and antiviral activities associated with antagonism of the neuropatic pain and, at very low doses, with cytoprotective and cytoregenerative activity against the cytodegenerative diseases.. .
08/14/14
20140228361
new patent Aminoquinazoline derivatives and their salts and methods of use
The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling.
08/14/14
20140228315
new patent Blockade of eosinophil production by toll-like receptors
It has long been known that eosinopenia is observed during acute bacterial infection yet the mechanism remains undefined. Herein, we investigated the consequence of exposure to microbial products, specfically bacterial lipopolysaccharide (lps), on eosinophil production.
08/14/14
20140228246
new patent Ecm composition, tumor microenvironment platform and methods thereof
The present disclosure relates to an extra cellular matrix composition specific for cancer type and a tumor microenvironment platform for long term culturing of tumor tissue, wherein said culturing provides human ligands and tumor tissue micro-environment to mimic physiologically relevant signalling systems. The present disclosure further relates to the development of a clinical response predictor and its application in the prognostic field (selection of treatment option for the patient) and translational biology field (development of anticancer drugs).
08/14/14
20140228075
new patent Functional support system for cellular phone or related devices
The present invention relates to a support system for a cellular device that allows for the upright free standing of said cellular device, and relates more particularly to a cellular device that allows for the upright free standing of said cellular device with the incorporation of one of a headphone set, charging device, a nano, or a gaming control panel or the combination thereof within said upright standing support system.. .
08/14/14
20140228040
new patent Tail optimization protocol for cellular radio resource allocation
Power and resource efficiency of a mobile network device are increased. In one aspect, a tail optimization protocol (top) enables cooperation between a mobile device and an associated radio access network to eliminate idle periods (e.g., tails) when possible.
08/14/14
20140228039
new patent Facilitating multiple subscriber identity support in a wireless device
Facilitating multiple subscriber identity support in a wireless user equipment (ue) device. A ue may include or be coupled to multiple subscriber identity modules (sims).
08/14/14
20140228036
new patent Overlapping cells for wireless coverage
A system is provided for overlapping cells for wireless coverage in a cellular communication system. The system includes a beam-weight generator and beamformer coupled to the beam-weight generator.
08/14/14
20140228035
new patent Multipoint-to-multipoint base station communication
A communication system includes at least first, second and third base stations (711, 722, 733, 744), which are configured to communicate over the air with mobile user equipment (203, 204) in a cellular communications network. Embedded user equipment (ue11, ue12, .
08/14/14
20140228031
new patent Neighbor selection for handover in a radio access network
The following methods are disclosed: a method of initiating handover of a user equipment, ue, in a cellular network comprising a plurality of enhanced node bs, enbs, the method comprising: receiving at a source enb, from the ue, a handover measurement report containing a physical cell identifier, pci, of a cell of a neighboring enb; at the source enb, performing a lookup of a neighbor relation relation table to identify a global cell identity and access mode associated with the pci; and using the identified global cell identity and the access mode to determine an enb identity for said neighboring enb. A method of initiating handover of a user equipment, ue, in a cellular net-work comprising a plurality of enhanced node bs, enbs, the method comprising: receiving at a source enb, from the ue, a handover measurement report containing a physical cell identifier, pci, of a cell of a neighboring enb; at the source enb, performing a lookup of a neighbor relation table to identify a plurality of global cell identities associated with the pci, the neighbor relation table also containing, for each such global cell identity, pcis of neighboring cells; selecting the correct global cell identity from said plurality of global cell identities by comparing the pcis of further neighboring enbs cells reported by the ue with the neighboring pcis of each of said plurality of global cell identities; and deriving from the selected correct global cell identity, an enb identity of said neighboring enb.
08/14/14
20140227766
new patent Purification of biological products by constrained cohydration chromatography
Materials and methods for use of constrained cohydration agents in the purification of biological materials such as antibodies, viruses, cells, and cellular organelles in connection with convective chromatography, fluidized bed or co-precipitation applications.. .
08/14/14
20140227741
new patent Biological systems for production of highest quality proteins
Vaccines and therapeutic proteins, including polyclonal and monoclonal antibodies, must be maximally pure and stable in their most active native form. This is a requirement for their maximal efficacy, specificity and stability as well as for precluding immune responses against erroneous or damaged moieties.
08/14/14
20140227712
new patent Rapid method for isolating extracellular nucleic acids
The present invention pertains to a method for isolating extracellular nucleic acids from a sample, wherein said sample is optionally stabilized, by binding the extracellular nucleic acids to a solid phase which carries anion exchange groups, comprising the following steps: binding the extracellular nucleic acids to the solid phase in a binding mixture having a first ph which allows binding the extracellular nucleic acids to the anion exchange groups of the solid phase; wherein the sample makes up at least 85% of the volume of the binding mixture; separating the solid phase with the bound extracellular nucleic acids; optionally washing the extracellular nucleic acids; optionally eluting extracellular nucleic acids from the solid phase. The method has the advantage that large sample volumes can be processed and that extracellular nucleic acids can be isolated rapidly with a high yield.
08/14/14
20140227688
new patent Stabilisation and isolation of extracellular nucleic acids
The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula (1) as defined in the claims.. .
08/14/14
20140227687
new patent Stabilisation and isolation of extracellular nucleic acids
The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula (1) as defined in the claims.. .
08/14/14
20140227426
new patent Methods of manufacturing drug-loaded substrates
Described are methods for modifying a substrate by exposing the substrate to a densified fluid. The substrate may be a polymer or a metal alloy, and the densified fluid may be carbon dioxide.
08/14/14
20140227364
new patent Methods of manufacturing bioactive gels from extracellular matrix material
The present invention is directed to methods of manufacturing bioactive gels from ecm material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ecm material can be created by digesting particularized ecm material in an alkaline environment and neutralizing to provide bioactive gels..
08/14/14
20140227362
new patent Methods of manufacturing bioactive gels from extracellular matrix material
The present invention is directed to methods of manufacturing bioactive gels from ecm material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ecm material can be created by digesting particularized ecm material in an alkaline environment and neutralizing to provide bioactive gels..
08/14/14
20140227344
new patent Cell penetrating peptides for intracellular delivery of molecules
The présent invention relates to cell-penetrating peptides characterized in that it comprises an amino acid séquence selected in the group consisting of x1lx2ralwx9lx3x9x4lwx9lx5x6x7x8, x1lx2larwx9lx3x9x4lwx9lx5x6x7x8 and x1lx2arlwx9lx3x9x4lwx9lx5x6x7x8, wherein x1 is beta-a or s, x2 is f or w, x3 is l, w, c or i, x4 is s, a, n or t, xs is l or w, x6 is w or r, x7 is k or r, x8 is a or none, and x9 is r or s. Thèse peptides exhibit high efficiency, low toxicity and a natural tropism for lung tissues, and can be used either in simple complex with the cargo to be vectorised, or in nanoparticles comprising two layers of cell-pentrating peptides around the cargo..
08/14/14
20140227293
new patent Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
The present invention provides methods and compositions for the treatment and prevention of angiogenesis, or cancer, e.g., metastatic cancer by administering an effective amount of an inhibitor of immunoglobulin containing proline rich receptor-1 (igpr-1) protein or expression. In particular, the present invention provides methods and compositions for the treatment and prevention of cancer by administering an effective amount of an inhibitor of immunoglobulin containing proline rich receptor-1 (igpr-1) protein or expression which is a soluble extracellular domain igpr-1.
08/14/14
20140227283
new patent Anti-axl antibodies and uses thereof
The present invention relates to anti-axl antibodies and uses thereof in diagnostic and therapeutic methods. More particularly, the present invention relates to a monoclonal antibody having specificity for axl comprising an heavy chain variable region comprising seq id no:2 in the h-cdr1 region, seq id no:3 in the h-cdr2 region and seq id no:4 in the h-cdr3 region; and a light chain variable region comprising seq id no: 6 in the l-cdr1 region, seq id no:7 in the l-cdr2 region and seq id no:8 in the l-cdr3 region.
08/14/14
20140227273
new patent Multi-specific binding molecules targeting aberrant cells
Described are proteinaceous molecules comprising at least two, preferably three to six, binding domains that bind specifically to at least two different binding sites on aberrant cells. These multi-domain and multi-specific binding molecules are preferably used in selectively modulating biological processes.
08/14/14
20140227265
new patent Method of treating or ameliorating metabolic disorders using clec-2
Methods of treating metabolic diseases and disorders using a clec-2 extracellular domain are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, elevated glucose levels, elevated insulin levels and elevated triglyceride levels..
08/14/14
20140227263
new patent Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
The present invention relates to the use of fibroblast growth factor receptor i (fgfr1) extracellular domain (ecd) polypeptides for treatment of cancers characterized by ligand dependent activating mutations in fibroblast growth factor receptor 2 (fgfr2). For example, the present invention relates to the treatment of endometrial cancers and other cancers wherein tumor cells express fgfr2 mutants in the igii-igiii hinge region or igiii domain of the protein, such as at amino acid positions 252 and/or 253..
08/14/14
20140227262
new patent Pd-1 antagonists and methods for treating infectious disease
Methods and compositions for treating an infection or disease that results from (1) failure to elicit rapid t cell mediated responses, (2) induction of t cell exhaustion, t cell anergy or both, or (3) failure to activate monocytes, macrophages, dendritic cells and/or other apcs, for example, as required to kill intracellular pathogens. The method and compositions solve the problem of undesired t cell inhibition by binding to and blocking pd-1 to prevent or reduce inhibitory signal transduction, or by binding to ligands of pd-1 such as pd-l1, thereby preventing (in whole or in part) the ligand from binding to pd-1 to deliver an inhibitory signal.
08/14/14
20140227254
new patent Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a ligand-binding portion of the extracellular domain of activin-like kinase i (alk1) polypeptide may be used to inhibit angiogenesis in vivo, particularly in mammals suffering angiogenesis-related disorders. In certain aspects, the disclosure demonstrates that antagonists of bmp9 and/or bmp10, ligands for alk1, may also be used to inhibit angiogenesis in vivo..
08/14/14
20140227229
new patent Modified gram positive bacteria and uses thereof
The present invention relates to gram positive bacteria with increased stress resistance and/or improved storage characteristics. In particular, the invention relates to gram positive bacterium which accumulate intracellular trehalose.
08/14/14
20140227185
new patent Glutathione-based drug delivery system
The invention relates to methods of targeted drug delivery of compounds, including, chemical agents, (poly)peptides and nucleic acid based drugs (like dna vaccines, antisense oligonucleotides, ribozymes, catalytic dna (dnazymes) or rna molecules, sirnas or plasmids encoding thereof). Furthermore, the invention relates to targeted drug delivery of compounds to extravascular and intracellular target sites within cells, tissues and organs, in particular to target sites within the central nervous system (cns), into and across the blood-brain barrier, by targeting to glutathione transporters present on these cells, tissues and organs.
08/14/14
20140227174
new patent Skin permeating and cell entering (space) peptides and methods of use therefor
Compositions that facilitate the delivery of an active agent or an active agent carrier wherein the compositions are capable of penetrating the stratum corneum (sc) and/or the cellular membranes of viable cells are provided. In some embodiments, the compositions include a peptide, an active agent, and a carrier that includes the active agent, wherein the peptide has an amino acid sequence set forth in any of seq id nos: 1-18; the peptide is associated with and/or conjugated to the active agent, the carrier, or both; the carrier is selected from the group consisting of a micelle, a liposome, an ethosome, and combinations thereof; and the composition is capable of penetrating a stratum corneum (sc) layer when contacted therewith or penetrating a cell when contacted therewith, and optionally wherein the composition further includes one or more free peptides having an amino acid sequence set forth in any of seq id nos: 1-18.


Popular terms: [SEARCH]

Cellular topics: Access Point, Neural Stimulation, Neurological, Ceramic Substrate, Communications, Die Assembly, Extracellular, Computing Device, Discomfort, Circuit Board, Modulation, Passive Intermodulation, Distributed, Transceiver, Distributed Antenna System

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Cellular for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cellular with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2902

3441

449589 - 0 - 75